INTERPHEX 2025: Advanced Flow Sensor Technologies Enable More Accurate Measurement

Published on: 
,

Michael Franco, global sales director at PSG Biotech, spoke with the PharmTech Group at INTERPHEX 2025 about recent advancements in pharmaceutical flow sensor technology.

Advertisement

At INTERPHEX 2025, Michael Franco, global sales director at PSG Biotech, spoke with the PharmTech Group about how recent advancements in pharmaceutical flow sensor technology focus on improving measurement accuracy as drug production becomes more expensive and precise. A key development, he notes, is the enhancement of Coriolis single-use flow meters, which now feature a higher turndown ratio. This enhanced feature allows a single sensor to accurately measure both high and low flow rates. With this innovation, inventory needs can be reduced, and sensor usability across various process conditions is extended, which improves sustainability.

“When we talk about high turndown ratio, it's very good for the industry, because with one sensor, you can measure more than just low flows or high flows. So, in terms of sustainability, there's less need for inventory, and the sensor can be used for longer, because it can be operated in different process conditions. [In] terms of the future, we're adding more digital communication platforms so customers can communicate to the sensors in different ways, making sure that the sensors talk to pumps, and to get a really good performance between the two. [Those] are the things that probably are going to be asked more and more from customers,” Franco says.

Looking forward, this integration of digital communication platforms to enhance sensor interoperability is expected to enable better coordination with pumps and optimize system performance. These advancements are increasingly demanded by customers for improved bioprocessing applications, including tangential flow filtration (TFF) and chromatography skids. The ongoing adoption of these technologies as observed at INTERPHEX, notes Franco, highlights their growing importance in pharmaceutical manufacturing.

INTERPHEX 2025 occurred in New York City on April 1–3.

Click above to view the full interview.

Click here for more conference coverage.

About the speaker

Michael Franco, Global Sales Director, PSG Biotech

Michael Franco leads the PSG Biotech global sales team, focused on strategic business growth, with a strong focus on adding value to PSG Biotech customers, and building meaningful and in-depth partnerships. Mike’s abilities to connect with customers and understand business strategy stem from a rich educational and career experience in key roles in multiple industries:

Prior to Biopharma, Mike worked in several sectors including Aerospace, Industrial, Renewable Energy and Power. He progressed from positions such as Researcher, Applications Engineer, Commercial Engineer, Segment Leader and Regional Sales Manager where he excelled and elevated to his current position as Director of Global Biopharma Sales. Companies that have been graced with Michael’s employed expertise include Syntest Corporation, Panametrics, GE Power Systems, GE Oil and Gas, GE Industrial, GE Energy Services, and AMETEK.

Michael’s education achievements include a Bachelor of Applied Science in Electrical Engineering from Boston University, a Master of Science in Information Technology at Worcester Polytechnic Institute, and a Master of Business Administration with a concentration in Business Administration and Management at the Isenberg School of Management at UMass Amherst.